Medline is an appealing investment candidate – it has solid growth, operates in a steady industry, and a storied history.

Medline Inc. (NASDAQ:MDLN) is one of the stocks Jim Cramer recently looked at. Asking about the stock, a caller mentioned that they started their position when it was at $39. Cramer commented: I’m ...

Medline's founding family (from left to right): Jim Abrams, Charlie Mills and Andy Mills. Five members of the Illinois-based Mills family joined the three-comma club on Wednesday, as the nearly ...

Medline, one of the world’s biggest makers of personal protective equipment, is considering filing for an initial public offering as early as this fall, according to several reports. Medline, which ...

Medline is looking to broaden its business with hospitals and grow through acquisitions after capping 2025 with the year’s ...

Medline shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...

Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report fourth quarter and full year 2025 financial ...

Shares of U.S. medical supplies giant Medline jumped in its debut on the Nasdaq on Wednesday after the biggest initial public offering of the year globally. Shares closed up more than 41% at $41 a ...

Event context and recent share performance Medline (MDLN) has come into focus after recent trading, with the share price last closing at $46. The stock shows modest positive returns over the past week ...

Medline shares surged more than 40% in their hotly anticipated New York debut on Wednesday, valuing the medical supply giant at $54 billion in the largest US initial public offering since Rivian’s ...

Medline has struck a series of new and expanded partnerships with health systems in recent months, reinforcing its position as a major supply chain player in both medical-surgical and laboratory ...